Raymond T. Keane - Chief Legal Officer at Cullinan Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Legal Officer
Stock Symbol
CGEM on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Raymond T. Keane since 12/22/2023

Holdings reported by Raymond T. Keane for Cullinan Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 24.1K $301K $12.46 Feb 11, 2022 Direct
Stock Option (Right to Buy) 45K Feb 11, 2022 Direct Common Stock

Transactions reported by Raymond T. Keane for Cullinan Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.